ChromaDex Reports Q1 2024 Results on May 8
24 Apr 2024 //
BUSINESSWIRE
Findings from Published Abstracts Showcase the Importance of NAD+ in Glaucoma
18 Jul 2023 //
BUSINESSWIRE
Thorne Research, Inc. Loses Patent Challenge Decision
15 Aug 2022 //
BUSINESSWIRE
ChromaDex Bags New U.S. Continuation Patent for Nicotinamide Riboside
09 Feb 2022 //
BUSINESSWIRE
Enforcement Report - Week of January 17, 2018
17 Jan 2018 //
FDA